- Open Access
Impacts and Burden of Niemann pick Type-C: a patient and caregiver perspective
Orphanet Journal of Rare Diseases volume 16, Article number: 493 (2021)
Niemann-Pick disease type C (NPC) is a debilitating condition that impacts patients’ and caregivers’ quality of life (QOL) and reduces the patient’s life expectancy. Since there is little qualitative research from the perspective of patients and family caregivers, this study explored the impact of NPC on patients’ and caregivers’ daily lives to understand the burden of disease.
A survey of caregivers for patients with NPC and adult patients with NPC (n = 49; patient age: 13 months–65 years) assessed NPC severity, importance of NPC symptoms, and how symptoms impacted patients’ and caregivers’ activities of daily living (ADLs) and health-related QOL (HRQOL). Follow-up interviews with a subset of survey participants (n = 28) explored the ranking of NPC symptom importance and impact on ADLs and HRQOL. Findings indicated that the most important manifestations of NPC were ambulation, swallowing, speech, fine motor skills, and cognition, which were those that had the most significant impact on ADLs and HRQOL. A wide range of ADLs were affected by NPC, mainly eating/drinking and the ability to perform daily tasks, including self-care, communicating, participating in school or work, and moving indoors as well as outside the home. Along with these impacts, there was an increased risk of experiencing dangerous or life-threatening situations leading to loss of patient independence and additional caregiver burden, often requiring changes in lifestyle such as giving up work. All aspects of patients’ and caregivers’ HRQOL were affected. Participants reported feelings of social isolation, loss of enjoyment in activities (patients), and feelings of sadness or worry (caregivers).
Ambulation, swallowing, speech, fine motor skills, and cognition are important manifestations of NPC. ADLs and HRQOL were impaired in the majority of patients as well as their caregivers. The findings were independent of current age, age of onset of symptoms, and level of NPC disease-related disability; however, the impact increased at higher levels of disease disability. Knowing the impact of NPC on patients and caregivers is important for understanding the lived experience of NPC and for identifying potential areas of support.
Niemann-Pick disease type C (NPC) is an ultra-rare, progressive, neurodegenerative disease that occurs in approximately 1:100,000 live births . NPC is a lysosomal storage disease caused by mutations in the NPC1 (≈ 95% of cases) or NPC2 (≈ 5% of cases) genes [2, 3], which encode lysosomal proteins essential for intracellular transport and the metabolism of lipids [4, 5]. The mutation of these genes leads to NPC proteins often being misfolded or degrading prematurely. This process causes an accumulation of cholesterol and lipids within cells and impaired lysosomal function [5, 6]. As a result, NPC initially can impact liver, spleen, and lung function but predominantly manifests as a progressive, neurogenerative disease leading to premature death. The clinical presentation and progression of NPC is heterogeneous, varying by age at the time of symptom onset; NPC most often manifests as a loss of motor function, coordination, and speech along with cognitive impairment [7,8,9,10]. Individuals whose neurological symptoms begin in early childhood generally have a faster disease progression than patients whose symptoms begin later . There is no cure for NPC. However, in recent years, several drug treatments have been considered for orphan drug status for NPC by the United States (US) Food and Drug Administration (FDA), including cyclodextrin [11, 12], miglustat , and most recently arimoclomol .
Regulatory agencies such as the FDA have increasingly emphasized the need to understand in greater detail clinical manifestations of rare diseases, their impact on individual patients and their families, and available treatments. For NPC in particular, this was highlighted during a recent patient-focused drug development (PFDD) meeting . To know the true impact and burden of the condition, both the patients’ and caregivers’ perspective on NPC are important for understanding how the disease impacts their day-to-day lives given the progressive and neurodegenerative aspects of NPC, which lead to increased need for caregiving as NPC progresses. As treatments become available that may slow the progression of NPC, it is important to gain the perspectives of patients and caregivers regarding their needs and how treatments may affect these needs.
Prior research has suggested that NPC has a significant impact on patients’ and caregivers’ quality of life (QOL) , especially on patients’ school or work lives and caregivers’ lives as NPC progresses . However, little qualitative research has been undertaken to understand more fully the impacts of NPC from the perspective of patients and caregivers. Interviews with patients and caregivers allow for a better understanding of NPC’s burden of illness on families, including its impacts on their day-to-day lives, by capturing patients’ and caregivers’ unique experiences.
Although the findings highlight the substantial burden associated with NPC for all, the precise nature of the impact and experience of NPC may differ depending on the range of symptoms experienced, the current age of the patient, and the patient’s age at symptom onset, which varies widely. Neonatal or infantile onset often leads to a more rapidly progressing fatal disorder while adult onset often manifests as a slowly progressing neurodegenerative disease . Patients may also experience different sets of symptoms (e.g., neuromotor or cognitive symptoms) at different ages [18–20]. Such heterogeneity of symptoms experienced and what timeframe they manifest will have different impacts on patients’ and caregivers’ lives. While prior research has noted the clinical importance of age of symptom onset and cluster of symptoms experienced, little research has been done looking at how these aspects of NPC affect the way it impacts patients and caregivers.
The purpose of this research was to explore how NPC impacts the daily lives of patients and caregivers and to understand the burden of disease, which is the cumulative consequences of NPC, including health and social aspects of the disease. The gap between an ideal situation where one is free of disease and disability, and the cumulated health status of having NPC, is defined as the burden of disease . Activities of daily living (ADLs) are an indicator of a person’s functional status that is used to collectively describe fundamental skills required to independently care for oneself such as eating, bathing, and mobility . Health-related QOL (HRQOL) is a multi-dimensional concept that includes domains related to physical, mental, emotional, and social functioning. It goes beyond direct measures of population health, life expectancy, and causes of death, and focuses on the impact health status has on QOL . Given the heterogeneity of symptom experience and general differences between child- and adult-onset, this research also sought to explore how the symptoms experienced lead to different impacts on patients’ and caregivers’ lives.
A total of 49 surveys were completed across two countries: 37 in the US and 12 in the United Kingdom (UK). Of the 49 completed surveys, 43 (87.8%) were completed by caregivers (reporting for 22 [51.2%] pediatric patients and 21 [48.8%] adult patients), and six (12.2%) of the surveys were completed by adult patients reporting for themselves. A subset of 28 survey participants completed the follow-up telephone interview (20 in the US and eight in the UK). Of those interviewed, 23 (82.1%) were caregivers (reporting for 10 [43.5%] pediatric patients and 13 [56.5%] adult patients), and five (17.9%) were adult patients. Of the 43 caregivers completing the survey, 40 were a parent of the patient, one sibling, one grandparent, and one aunt. All caregivers who were interviewed were parents. Besides relation to the patient, no additional demographics about the caregivers were collected in order to focus on the patient and reduce participant burden of completing the survey. Given the low number of adult patients reporting for themselves (i.e., six in the survey and five in the interview), the impact of NPC on patients’ ADLs and HRQOL are reported primarily from the point of view of caregivers. Overall, a broad range of current ages, age of onset, and NPC severity were included in both the survey and interview (Table 1).
Importance of symptoms
In the web survey, of the nine symptom domains participants were asked to rank in order of importance (see Table 8 for a definition of each as presented in the survey), the six symptom domains most frequently ranked in the top five of importance by 40% or more of participants were: (1) Ambulation; (2) Swallow; (3) Speech; (4) Memory; (5) Cognition; and (6) Fine motor. A summary of participants’ ranking of symptom importance is in Table 2. In the interviews, participants often noted that they regarded memory and cognition as difficult to differentiate.
There were no major differences observed in the rankings of symptom importance when participants were grouped according to current age of the patient, nor when they were grouped according to age at symptom onset. However, there were some differences in the rankings of symptom importance when grouped by disease severity (i.e., the 5-domain NPC Clinical Severity Scale [NPCCSS] score as reported by patients or caregivers). When comparing those in the least severe to most severe group on the 5-domain NPCCSS (total score ≤ 4 versus ≥ 20), those in the least severe group more frequently ranked ambulation and cognition in their top five of importance (n = 6/7 [85.7%] vs. n = 4/6 [66.7%] and n = 5/7 [71.4%] vs. n = 2/6 [33.3%], respectively). Conversely, those in the more severe group more frequently ranked swallowing in their top five of importance than those in the less severe group (n = 6/6 [100%] vs. n = 3/7 [42.9%]).
The greater frequency of swallowing’s importance was also highlighted qualitatively in the interviews when caregivers discussed their reasons for ranking swallowing in their top five of importance. As one caregiver of a 24-year-old male with a 5-domain NPCCSS total score of 15 noted about what the increased risk swallowing difficulties meant, “I’d rather keep him from choking. […] Things that could cause him to die, those are my scary things.” Similarly, the caregiver of a 28-year-old male with a 5-domain NPCCSS score of 23 said, “He’s [at] risk feeding at the moment um, and we have recently had an appointment for uh-uh a PEG feed. […] He’s not had any chest infections yet, but it has deteriorated.”
Overview of impacts: results of web survey
In the web survey, participants reported a variety of symptoms having an impact on the patient’s own ADLs and HRQOL as well as that of the caregiver or other family members as summarized in Table 3. Among caregivers reporting in the survey, the domains most commonly reported to impact patients ADLs and HRQOL “a lot” or “extremely” were the patient’s ambulation, swallowing, and cognitive symptoms. Caregivers reported speech and fine motor skills as impacting patients’ ADLs and HRQOL, too, but more frequently endorsed the response options of “somewhat” or “moderately” for these symptoms.
Overall, for each symptom domain, a broad range of impact was reported (from “not at all” to “extremely”), suggesting that the individual experience may be quite heterogeneous. However, the majority of participants reported being impacted by NPC to some extent (i.e., at least two-thirds reported some level of impact on each symptom). Even though patients overall were reported in the survey by their caregiver to be at a moderate disease level (mean 5-domain NPCCSS score = 12.0), 71.4% or more reported the patient’s ADLs or HRQOL being impacted at least “somewhat” by each symptom. Similarly, for the six adult patients who reported for themselves and who were at a less severe disease level (mean 5-domain NPCCSS Score = 7.8), 67.7% or more reported their own ADLs or HRQOL as being impacted at least “somewhat” by each symptom.
Key impacts on patients
NPC had a considerable impact upon both ADLs and HRQOL of patients and the two, ADLs and HRQOL, were interrelated. In the interviews, caregivers and patients reported NPC symptoms had an impact on several ADLs, such as difficulties with fine motor skills and swallowing impacting patients’ eating or drinking, and having to stop or having difficulties with previous activities, which were most commonly reported, and problems with self-care and personal hygiene as summarized in Fig. 1. These impacted ADLs in turn affected patients’ HRQOL (see Fig. 2). Example quotes are given in Table 4 to illustrate the impacts of NPC on ADLs.
These impacts on patients’ ADLs arose from several different symptoms. Difficulty eating or drinking was often reported as a result of the patient’s swallowing difficulties (n = 17; 60.7%) or difficulties with fine motor skills (n = 12; 42.9%). Having to give up, or having difficulty continuing, previous activities often resulted from difficulties with fine motor skills (n = 12; 42.9%) and cognitive difficulties (n = 8; 28.6%). Difficulties with speech (n = 11; 39.3%) and cognition (n = 4; 14.3%) most frequently led to the impact of having difficulty understanding/communicating. Ambulation symptoms often contributed to patients’ having difficulty moving indoors (n = 7; 25.0%), having difficulty with tasks outside the home (n = 6; 21.4%), and needing assistance with daily tasks (n = 8; 28.6%), including self-care activities such as going to the bathroom (n = 4; 14.3%). Impacts on school or work often stemmed from cognitive difficulties (n = 8; 28.6%) or difficulties with memory (n = 7; 25.0%).
NPC and the impact it has upon ADLs also has a further effect upon patients’ HRQOL in a number of ways, with considerable impact on all major domains of HRQOL: emotional (n = 26; 92.9%), physical (n = 24; 85.7%), psychological (n = 10; 35.7%), and social (n = 22; 78.6%). The most frequently cited (n = 18; 64.3%) emotional impact on patients from the caregiver perspective was patients feeling frustrated about their disease progression across multiple symptoms including speech, fine motor, and cognition or memory. Regarding the physical well-being aspects of patients’ HRQOL, participants discussed issues directly related to NPC such as the risks of dangerous situations, falling and being less active, but most frequently reported patients being more susceptible to other health concerns, such as weight loss, sleep inversion, or respiratory problems (n = 10; 35.7%). In terms of social well-being, it was commonly reported that NPC made patients less social overall and more socially isolated because they found it more difficult to travel to visit others or because they had greater difficulty communicating. Example quotes are given in Table 5 to illustrate these impacts upon HRQOL.
Key impacts on caregivers
NPC not only impacted patients’ ADLs and HRQOL but also that of the caregivers (see Figs. 3 and 4). Participants frequently noted that NPC led to a change in caregivers’ daily lives, requiring changes to daily behavior and additional demands upon their time and mental energy. Practical aspects of life such as increased supervision of meals and challenges related to transportation, particularly the difficulties or adjustments needed to accommodate the patient’s wheelchair when travelling were also discussed as affecting the caregivers’ ADLs. A summary of these findings with example quotes from the interviews is presented in Table 6.
The impact of NPC on caregivers’ HRQOL was reported by many participants (n = 15; 53.6%) as summarized in Table 7, which also presents example quotes to illustrate the impact. Emotional impacts were those most commonly reported by caregivers, who discussed feelings of sadness, worry, anxiety, or distress about the impacts NPC was having on the patient, and reported feeling they were always on alert, being concerned about the patient suffering an injury, illness, or deteriorating due to their NPC. Caregivers also reported impacts on their own social well-being, with limitations to their activities and feelings of isolation, and physical impacts for some who had difficulty lifting the patient.
Impact of NPC by degree of disability
How exactly NPC impacted patients and caregivers depended on the degree of disability. When speaking specifically about ambulation, the majority of participants reported that it impacted ADLs or HRQOL at least somewhat (Table 3). Participants across all degrees of disability discussed the impact ambulation symptoms had specifically on patients’ needing assistance with daily tasks (n = 8; 28.6%). Those with a lower degree of disability tended to talk more about problems indoors; of the seven (25.0%) participants who spoke about this, most (n = 5/7; 71.4%) had severity scores of between 5 and 9 on the 5-domain NPCCSS. However, at higher degrees of disability, ambulation symptoms appeared to have a greater impact on patients’ activities outside the home, required a greater need for assistance, or were more likely to be associated with having to stop doing certain activities. Of the six (21.4%) participants who spoke about ambulation impacting patients’ tasks outside the home, most (n = 4/6; 66.7%) had a severity score of 10 or greater.
How NPC impacted a patient’s ability to communicate or understand communication also varied depending on the degree of disability. In those at lower levels of disability (n = 11 with a 5-domain NPCCSS score of less than 10), a typical impact reported was needing to repeat oneself or having difficulty pronouncing words (n = 3/11; 27.3%), which was noted by a 51-year-old female patient with a severity score of 5: “I feel like I talk just fine. And if people don’t understand me, they ask me again. I’ll repeat what I said.” However, in those with a higher degree of disability (n = 17 with a 5-domain NPCCSS score of 10 or greater), it was often reported that patients struggled to express their needs or were no longer able to communicate at all with those they were unfamiliar with (n = 5/17; 29.4%): “He very rarely verbally communicates. So, um I mean it’s okay for us but if [it’s] somebody from outside [the family], he can’t communicate alone.” (Caregiver of 28-year-old male with a severity score of 23).
Cognitive impairment led to difficulty at school or work for patients (n = 8; 28.6%) across all degrees of disability from 5-domain NPCCSS scores of 5 and above. However, for those at higher degrees of disability, cognitive symptoms had a greater impact on patients’ ability to communicate: “And it’s hard to, like, get her attention back on what I’m trying to convey to her.” (Caregiver of 8-year-old female with severity score of 13). Of the four (14.3%) participants who described cognitive symptoms’ impacting patients’ ability to communicate and understand, all had 5-domain NPCCSS scores of 10 or higher.
Impact of NPC by age
Overall, impacts on patients’ ADLs were generally consistent across age with some exceptions. For instance, impacts on former activities for pediatric patients were often about no longer being able to do “child” things like playing with peers: “You know, we try to let him have fun. […] He’s not as free to do stuff as other kids would be.” (Caregiver of 8-year-old male). For adults, though, more domestic activities like writing or gardening were impacted: “I do notice when I’m out gardening or doing things like that, you know, my hand, it gets cramped.” (34-year-old male patient).
Caregivers of pediatric patients were often more concerned with their ability to keep up with peers or even attend school: “Can I send him to pre-school and he will be able to participate?” (Caregiver of 2-year-old male). For adults, though, the impact was more about being able to work or maintain work: “I work on a computer. And so many times now I need to, you know, double check what I’ve typed […] because I don’t have the fine motor skills I used to have.” (51-year-old female patient).
Daily tasks were also impacted in different ways for pediatric and adult patients. For children, caregivers discussed patients’ basic ADLs like eating and dressing: “So, dressing himself is harder, brushing his teeth is harder, you know, to where he needs assistance with it.” (Caregiver of 5-year-old male). While for adults, participants also discussed more complex tasks like managing money or finances: “He couldn’t problem solve some of the things that had come up that he previously had no issue with. Whether it be the cash register or, you know, dealing with the finances of the business.” (Caregiver of 32-year-old male).
How NPC impacted patients’ HRQOL also varied by the age of the patient. For instance, older adult patients (≥ 30 years of age) or their caregivers more commonly talked about the psychological impacts of NPC on patients (n = 5; 17.9%) than younger adult patients 18 to 29 years of age (n = 3; 10.7%) or pediatric patients under the age of 18 years (n = 2; 7.1%). These included loss in language skills: “He’s also struggling with his voice now and he can’t remember words and he’s finding it very difficult to talk fluently.” (Caregiver of 45-year-old male). They also included a change in the patient’s personality: “It impacts personality, you know, [Patient] was always a quiet person, but you know I think he’s always been a happy, outgoing person. Um- and we see that, you know, he’s not quite as much anymore because he has less interpersonal interactions.” (Caregiver of 32-year-old).
Patients’ age also impacted how caregivers’ daily activities were affected. For younger patients (29 years or younger), more caregivers expressed the need to alter their own behavior (n = 14; 50.0%) than caregivers of patients 30 years or older (n = 2; 7.1%). Conversely, more caregivers of adult patients 18 years or older talked about the patient requiring additional caregiving (n = 12; 66.7%) than caregivers of pediatric patients under the age of 18 years (n = 4; 14.3%). Relatedly, needing to guess what patients needed was particularly relevant to caregivers of pediatric patients. All caregivers who expressed this impact in the interview (n = 5; 17.9%) were caregivers of patients under the age of 18 years.
In the interviews, the unique way in which NPC impacted adult patients was a common theme. Caregivers of adults often raised issues of consent and decision making that are more difficult with adult patients than with children: “With young children you make the decisions for your children. With adults that doesn’t happen all the time and you have to make the decisions with them and that’s often difficult.” (Caregiver of 32-year-old male).
Some caregivers also mentioned how patients have more support while they are school age; however, after they finish school there is less support for them in terms of work: “I think also it’s hard coming out of education and there’s kind of nothing. It’s really hard to know what to do with a kid who’s not getting any job opportunities because there’s some difficulties, but still is too able too capable to, to just put into a, care situation, where, you know, they, they wouldn’t be engaged sufficiently.” (Caregiver of 18-year-old female).
Impact of NPC by age of symptom onset
The impact of NPC also did not vary considerably according to the age of the patient at symptom onset. When comparing patients whose symptoms started before the age of 15 (n = 20) to those whose symptoms began after this age (n = 8), the most commonly reported impacts on the patients’ ADLs in both groups included it being more difficult to do tasks (n = 18/20; 90.0% versus n = 8/8; 100%, respectively), and having more difficulty or having to stop former activities (n = 14/20; 70.0% versus n = 5/8; 62.5%, respectively). In those whose symptoms started before the age of 15, having difficulty communicating or understanding (n = 13/20; 65.0%) and having greater dependence on caregivers (n = 11/20; 55.0%) were also commonly reported. For those whose symptoms began after the age of 15 years, impact upon school or work was also commonly reported (n = 5/8; 62.5%).
Although the general impacts felt were consistent across groups defined by age of symptom onset, precisely how or why patients had more difficulty or had to stop former activities varied. For those whose symptoms began as children, seizures or difficulties with ambulation often impacted their former activities such as playing: “There are a lot of things she used to be able to do […] she used to at least toss the ball or try to push it.” (Caregiver of 17-year-old female whose symptoms began at 10 years). For those whose symptoms began as adolescents or young adults, it was often fine motor skills having an impact on handwriting that were noted: “She was doing um, an exam she had to either use a computer or somebody that’s doing the typing for her […] because her handwriting is so slow and it’s quite uneven.” (Caregiver of 18-year-old female whose symptoms began at 13 years).
Symptoms relating to ambulation, swallowing, speech, fine motor skills, and cognition were rated as most important by participants, and this rating was consistent across age groups. Difficulties with ambulation and swallowing were highly salient symptoms to the participants interviewed in this study. Results also suggested that at higher levels of NPC severity, swallowing seemed to be more important than symptoms associated with ambulation or cognition. This may be because once patients reach a stage of severity in which they are not moving about independently they have less risk of falls, whereas swallowing and the life-threatening risks associated with that (e.g., choking) become the key symptom to manage. This finding of key symptoms, which were common across age groups, age of onset, and by degree of disability, is consistent with previous NPC research studies which also found these were the most important symptoms [15, 24]. It therefore suggests that these five symptoms are key for understanding the impact of NPC and should be integral to the clinical management of NPC and the evaluation of therapeutic interventions for NPC patients. It also provides additional support that the 5-domain NPCCSS measures five of the most important symptoms of NPC to caregivers and patients .
The impacts described by participants centered around mobility, self-care, ability to do previous activities, and emotional impacts such as feelings of anxiety or depression. Mobility issues both in terms of moving around inside and outside the house as well as issues around transportation were often reported by participants. Activities of self-care were often discussed by participants as patients experienced difficulty with personal hygiene activities, often requiring additional caregiving support for these activities. A key impact of NPC reported by participants was patients having difficulty or no longer being able to undertake previous activities and, as a result, experiencing greater social isolation. Furthermore, the emotional impacts of NPC, including feelings of frustration, anxiety, fear, and worry were often reported.
As the majority of interview participants were caregivers, the emotional impacts of NPC on patients, such as feelings of frustration, were informed by their interpretation of patients’ behavior. For example, as the caregiver of a 16-year-old male said, “People have trouble understanding him, so it’s frustrating for them, and it’s frustrating for us. Um, I think it’s frustrating for him, but he doesn’t say it’s frustrating for him.” Future research may want to confirm with patients themselves, where possible, that they experience feelings of frustration or similar impacts that are difficult for an observer to know directly.
The degree of disease disability according to the 5-domain NPCCSS scores not only reflected the severity of the patient’s NPC but also how the disease impacted daily life. For instance, at lower levels of disability, patients may need to be more mindful when moving around indoors, but they do not necessarily need to make adjustments to their homes. At higher levels of disability, though, patients may need to adjust their home environment to accommodate them. Similarly, at higher levels of disability, activities outside the home and communicating with others were more difficult, possibly leading to greater social isolation. These findings suggest that as the degree of disability progresses, the degree of impact NPC has on patients and caregivers similarly increases.
Participants in this survey and follow-up interview study were very engaged and willing to share their experiences, leading to a considerable amount of rich, qualitative data to inform understanding of the patient and caregiver experience of NPC. Findings from this study on the burden of NPC highlight areas that are most salient to patients and caregivers and which should be considered by relevant stakeholders in public health and those who support the community of NPC patients and their caregivers. The impacts NPC can have on mobility and ADLs, both inside and outside the home, and practical challenges such as transportation are of critical importance. This research has also clearly demonstrated that NPC has a dramatic impact upon both the patients and also their caregivers, in terms of ADLs and all aspects of HRQOL (social, emotional, and physical), and that support is needed to help individuals in these areas in addition to finding treatments for the symptoms of NPC.
There are some limitations of the current study and implications for future research that are important to note. In this study, the study activities were primarily completed by caregivers rather than patients. Given NPC’s impact on fine motor skills, cognition, and speech, many patients were not able to complete the web survey on their own or be interviewed over the telephone. Ethical considerations also limited participants to be either adult patients or caregivers, meaning pediatric patients could not take part in study activities on their own and their experiences of NPC symptoms and impacts could only be captured by proxy report of the caregiver. If greater self-report could be obtained, this would help further confirm that the impacts of NPC raised by caregivers in this study are also what is of most importance to patients themselves. As this study was able to include several patients self-reporting for themselves, whose responses were similar to caregivers, it provides some provisional support that the impacts reported by caregivers are also the impacts of greatest importance to patients themselves.
The study originally intended telephone interviews to be approximately 60 min; however, after the initial interviews overran, the interview time was extended to approximately 90 min. Although this may have increased participant burden, those involved were highly engaged and willing to take part in longer interviews. Given the long diagnosis process, the complexity of presentation, and the multitude of ways in which NPC impacts people’s day-to-day lives, even the extended interview time did not enable all aspects of patients’ and caregivers’ experiences to be covered. Future studies should anticipate longer interviews or may want to consider having multiple interviews with patients and caregivers to get a fuller picture of their experiences with NPC and its impacts.
NPC profoundly impacts patients’ ADLs and HRQOL in a number of ways. The results confirm that ambulation, swallowing, speech, fine motor skills, and cognition are the most important manifestations. ADLs and HRQOL were impaired in the majority of patients as well as their caregivers, which was independent of current age and age of onset of symptoms. Impacts were also reported across all levels of NPC disease-related disability, although how exactly NPC impacted patients and caregivers varied by the degree of disability, with greater impact at higher levels of disease disability.
Knowing the impacts and burden of NPC on patients and caregivers is important for understanding patients’ and caregivers’ lived experience of NPC as well as for revealing the areas of support patients and caregivers need most. This study has begun to increase that understanding, pointing to the needs patients—particularly adult patients—and caregivers have in terms of greater support for providing care, transportation of the patient, more resources for adults with NPC, and emotional and mental health support for both patients and caregivers.
Adult (≥ 18 years of age) NPC patients, and caregivers of pediatric (< 18 years of age) or adult patients with NPC, were recruited into the study. The study had two parts: Part 1, a web-based survey; and Part 2, a follow-up telephone interview. A subset of the web-based survey participants took part in the follow-up telephone interview. To ensure the study activities (i.e., survey and interview) would be as applicable and sensitive as possible to the lived experience of patients with NPC and their caregivers, two patient advocacy groups (PAGs) provided feedback on the study design, protocol, and associated documents. Both PAGs also invited a caregiver who was a member of their organization to review the content of the web-based survey and interview and provide feedback to improve the clarity of the content, instructions, and questions.
In the web-based survey, participants (patients or caregivers) were asked to assess the patient’s NPC disease status, rating the severity of the nine major domains within the NPCCSS [25, 26]. Each item was adapted from the clinician-reported NPCCSS to be suitable for reporting by caregiver or patient while maintaining the scoring structure. Ratings of severity across these nine domains were used to calculate the patient’s 5-domain NPCCSS score (a total score is yielded ranging from 0 to 25). The 5-domain NPCCSS scores were used to stratify patients for the interview.
Participants were then asked in the survey to identify and rank the five most important NPC symptoms to them from 1 = “the very most important symptom” to 5 = “the least important symptom.” In this ranking exercise, participants could choose from 9 symptoms listed (see Table 8), which corresponded with the 9 major domains of the NPCCSS and any additional symptoms found relevant by the participant.
For each of the five most important symptoms ranked by participants, in addition to any of the symptoms within the 5-domain NPCCSS that were not selected, participants were asked follow-up questions to indicate the impact of that symptom on the ADLs and HRQOL for patients and caregivers respectively. Responses to these questions were given on a 5-point Likert scale of “Extremely,” “A lot,” “Moderately,” “Somewhat,” or “Not at all.”
The sub-group of participants who then went on to take part in the semi-structured telephone interviews were asked in greater detail about the five symptoms that they indicated as being important in the survey, why participants had included these symptoms in their top five, the patient’s experience of that symptom, and the impact it has had on the ADLs and HRQOL of both patients and caregivers. The interviewer also asked about the patient’s experiences with and impacts of any symptoms of the 5-domain NPCCSS that were not included in the participants ranking of the top five symptoms in the survey.
Participant recruitment was conducted through PAGs who work closely with the NPC community. In the US, this was the National Niemann-Pick Disease Foundation (NNPDF); in the UK, it was the Niemann-Pick UK (NPUK). Each PAG advertised the research study to their member community via email blast, a post on the PAG’s website or social media profiles, or personalized emails sent to individual members. Individuals interested in participating then directly contacted the researchers to be granted access to the web-based survey. The survey included electronic informed consent. The aim of the study was to receive 60 completed surveys across the two countries. As part of the survey, participants could express interest in being contacted to take part in the follow-up telephone interview. Those who expressed such interest were contacted on a first come, first served basis to schedule the telephone interview with the aim to collect information from at least half of the survey respondents (i.e., 30 completed interviews).
Availability of data and materials
The datasets generated and/or analyzed during the current study are not publicly available but are available from the corresponding author on reasonable request.
Activities of daily living
Food and Drug Administration
Health-related quality of life
Niemann-Pick disease type C
Niemann-Pick Type C Clinical Severity Scale
Patient advocacy group
Patient focused drug development
Quality of life
Geberhiwot T, Moro A, Dardis A, et al. Consensus clinical management guidelines for Niemann-Pick Disease Type C. Orphanet J Rare Dis. 2018;13(1):50.
Hammond N, Munkacsi A, Sturley S. The complexity of a monogenic neurodegenerative disease: more than two decades of therapeutic driven research into Niemann-Pick type C disease. Biochim Biophy Acta Mol Cell Biol Lipids. 2019;1864:1109–23.
Vanier M. Niemann-Pick disease type C. Orphanet J Rare Dis. 2010;5(16). https://doi.org/10.1186/1750-1172-1185-1116.
Naureckiene S, Sleat D, Lackland H, et al. Identification of HE1 as the second gene of Niemann-Pick C disease. Science. 2000;290:2298–301.
Lloyd-Evans E, Platt F. Lipids on trial: the search for the offending metabolite in Niemann-Pick Type C Disease. Traffic. 2010;11(4):419–28.
Platt F, d’Azzo A, Davidson B, Neufeld E, Tifft C. Lysosomal storage diseases. Nat Rev Dis Primers. 2018;4(1):27.
Vanier M. Niemann-Pick disease type C. Orphanet J Rare Dis. 2010;5:16. https://doi.org/10.1186/1750-1172-1185-1116.
Wraith J, Sedel F, Pineda M, et al. Niemann-Pick type C Suspicion Index tool: analyses by association of manifestations. J Inherit Metab Dis. 2014;37:93–101.
Patterson M, Clayton P, Gissen P, et al. Recommendations for the detection and diagnosis of Niemann-Pick disease type C: an update. Neurol Clin Prac. 2017;7:499–511.
Stampfer M, Theiss S, Amraoui Y, Jiang X, Keller S, Ory D. Niemann-Pick disease type C clinical database: cognitive and coordination deficits are early disease indicators. Orphanet J Rare Dis. 2013;8:35. https://doi.org/10.1186/1750-1172-1188-1135.
Maarup TJ, Chen AH, Porter FD, et al. Intrathecal 2-hydroxypropyl-beta-cyclodextrin in a single patient with Niemann-Pick C1. Mol Genet Metab. 2015;116(1-2):75–9.
Matencio A, Navarro-Orcajada S, González-Ramón A, García-Carmona F, López-Nicolás JM. Recent advances in the treatment of niemann pick disease type c: a mini-review. Int J Pharm. 2020:119440.
Patterson MC, Vecchio D, Prady H, Abel L, Wraith JE. Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study. Lancet Neurol. 2007;6(9):765–72.
Patterson M, Mengel E, Bembi B, et al. Efficacy and safety of arimoclomol in patients with Niemann-Pick disease type C: results from a double-blind, randomized placebo-controlled trial with a novel treatment. Mol Genet Metab. 2020;129(2):S127.
A Parseghian. Niemann-Pick type C patient and caregiver voices: externally-led, patient-focused drug development meeting (2019). https://nnpdf.org/files/2019/09/NPC-PFDD-Voice-of-the-Patient-report-09162019.pdf. Accessed June 8, 2020.
Patterson MC, Hendriksz CJ, Walterfang M, Sedel F, Vanier MT, Wijburg F. Recommendations for the diagnosis and management of Niemann–Pick disease type C: an update. Mol Genet Metab. 2012;106(3):330–44.
Wraith J, Imrie J. Understanding Niemann-Pick disease type C and its potential treatment. Malden: Blackwell Publishing; 2007.
Di Lazzaro V, Marano M, Florio L, De Santis S. Niemann–Pick type C: focus on the adolescent/adult onset form. Int J Neurosci. 2016;126(11):963–71.
Sévin M, Lesca G, Baumann N, et al. The adult form of Niemann–Pick disease type C. Brain. 2006;130(1):120–33.
Walterfang M, Velakoulis D. Niemann-Pick disease type C in adulthood: a psychiatric and neurological disorder. Eur Psychiatr Rev. 2010;3:16–20.
Hessel F. Burden of disease. Encyclopedia of Public Health. Available at: https://link.springer.com/referenceworkentry/10.1007%2F978-1-4020-5614-7_297#:~:text=The%20term%20burden%20of%20disease,aspects%2C%20and%20costs%20to%20society. Accessed September 24, 2020.
Edemekong PF, Bomgaars DL, Sukumaran S, et al. Activities of Daily Living (ADLs) [Updated 2020 Jun 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470404/. Accessed August 20, 2020.
Office of Disease Prevention and Health Promotion. Health-Related Qualit of Life and Well-being. Available at: https://www.healthypeople.gov/2020/about/foundation-health-measures/Health-Related-Quality-of-Life-and-Well-Being#:~:text=Health%2Drelated%20quality%20of%20life%20(HRQoL)%20is%20a%20multi,has%20on%20quality%20of%20life. Accessed August 20, 2020.
Cortina-Borja M, te Vruchte D, Mengel E, et al. Annual severity increment score as a tool for stratifying patients with Niemann-Pick disease type C and for recruitment to clinical trials. Orphanet J Rare Dis. 2018;13(1):143.
Patterson M, Lloyd-Price L, Guldberg C, et al. Validation of a short-form 5-domain Niemann-Pick type C clinical severity scale. Orphanet J Rare Dis. (in preparation).
Yanjanin N, Velez J, Gropman A, et al. Linear clinical progression, independent of age of onset, in Niemann-Pick disease, type C. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(1):132–40.
The authors would like to thank the patients, caregivers, and families for sharing their experiences with us, making this research possible. Editorial services were provided by Clinical Outcomes Solutions.
This study was funded by Orphazyme A/S.
Ethics approval and consent to participate
All study procedures were in accordance with ethical standards of the 1964 Helsinki Declaration and its later amendments, relevant laws, institutional guidelines, and approved by the institutional review board (IRB) Copernicus Group in the US and the London – Hampstead Research Ethics Committee (REC) in the UK. Participant informed consent (written or verbal) was obtained as approved by the IRB.
Consent for publication
CG and CD are employees of Orphazyme A/S. TS, MP, MC, CB, LLP, EM, TM, and JC declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article belongs to the Topical Collection: Lysosomal storage diseases.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Mengel, E., Patterson, M.C., Chladek, M. et al. Impacts and Burden of Niemann pick Type-C: a patient and caregiver perspective. Orphanet J Rare Dis 16, 493 (2021). https://doi.org/10.1186/s13023-021-02105-8
- Niemann pick Type-C
- Illness burden